Thomas M Runge1, Swathi Eluri1, Cary C Cotton1, Caitlin M Burk1, John T Woosley2, Nicholas J Shaheen1,3, Evan S Dellon1,3. 1. Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. 2. Department of Pathology and Laboratory Medicine; University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. 3. Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Abstract
OBJECTIVES: Esophageal dilation is commonly performed in eosinophilic esophagitis (EoE), but there are few long-term data. The aims of this study were to assess the safety and long-term efficacy of esophageal dilation in a large cohort of EoE cases, and to determine the frequency and predictors of requiring multiple dilations. METHODS: We conducted a retrospective cohort study in the University of North Carolina EoE Clinicopathological Database from 2002 to 2014. Included subjects met consensus diagnostic criteria for EoE. Clinical, endoscopic, and histologic features were extracted, as were dilation characteristics (dilator type, change in esophageal caliber, and total number of dilations) and complications. Patients with EoE who had undergone dilation were compared with those who did not and also stratified by whether they required single or multiple dilations. RESULTS: Of 509 EoE patients, 164 were dilated a total of 486 times. Those who underwent dilation had a longer duration of symptoms before diagnosis (11.1 vs. 5.4 years, P<0.001). Ninety-five patients (58%) required >1 dilation (417 dilations total, mean of 4.4±4.3 per patient). The only predictor of requiring multiple dilations was a smaller baseline esophageal diameter. Dilation was tolerated well, with no major bleeds, perforations, or deaths. The overall complication rate was 5%, primarily due to post-procedural pain. Of 164 individuals dilated, a majority (58% or 95/164) required a second dilation. Of these individuals, 75% required repeat dilation within 1 year. CONCLUSIONS: Dilation in EoE is well-tolerated, with a very low risk of serious complications. Patients with long-standing symptoms before diagnosis are likely to require dilation. More than half of those dilated will require multiple dilations, often needing a second procedure within 1 year. These findings can be used to counsel patients with fibrostenotic complications of EoE.
OBJECTIVES:Esophageal dilation is commonly performed in eosinophilic esophagitis (EoE), but there are few long-term data. The aims of this study were to assess the safety and long-term efficacy of esophageal dilation in a large cohort of EoE cases, and to determine the frequency and predictors of requiring multiple dilations. METHODS: We conducted a retrospective cohort study in the University of North Carolina EoE Clinicopathological Database from 2002 to 2014. Included subjects met consensus diagnostic criteria for EoE. Clinical, endoscopic, and histologic features were extracted, as were dilation characteristics (dilator type, change in esophageal caliber, and total number of dilations) and complications. Patients with EoE who had undergone dilation were compared with those who did not and also stratified by whether they required single or multiple dilations. RESULTS: Of 509 EoE patients, 164 were dilated a total of 486 times. Those who underwent dilation had a longer duration of symptoms before diagnosis (11.1 vs. 5.4 years, P<0.001). Ninety-five patients (58%) required >1 dilation (417 dilations total, mean of 4.4±4.3 per patient). The only predictor of requiring multiple dilations was a smaller baseline esophageal diameter. Dilation was tolerated well, with no major bleeds, perforations, or deaths. The overall complication rate was 5%, primarily due to post-procedural pain. Of 164 individuals dilated, a majority (58% or 95/164) required a second dilation. Of these individuals, 75% required repeat dilation within 1 year. CONCLUSIONS: Dilation in EoE is well-tolerated, with a very low risk of serious complications. Patients with long-standing symptoms before diagnosis are likely to require dilation. More than half of those dilated will require multiple dilations, often needing a second procedure within 1 year. These findings can be used to counsel patients with fibrostenotic complications of EoE.
Authors: James V Egan; Todd H Baron; Douglas G Adler; Raquel Davila; Douglas O Faigel; Seng-lan Gan; William K Hirota; Jonathan A Leighton; David Lichtenstein; Waqar A Qureshi; Elizabeth Rajan; Bo Shen; Marc J Zuckerman; Trina VanGuilder; Robert D Fanelli Journal: Gastrointest Endosc Date: 2006-05 Impact factor: 9.427
Authors: Seema S Aceves; Robert O Newbury; Ranjan Dohil; John F Bastian; David H Broide Journal: J Allergy Clin Immunol Date: 2007-01 Impact factor: 10.793
Authors: Ganapathy A Prasad; Nicholas J Talley; Yvonne Romero; Amindra S Arora; Lori A Kryzer; Thomas C Smyrk; Jeffery A Alexander Journal: Am J Gastroenterol Date: 2007-08-31 Impact factor: 10.864
Authors: Anil Mishra; Meiqin Wang; Venkatarajani R Pemmaraju; Margaret H Collins; Patricia C Fulkerson; J Pablo Abonia; Carine Blanchard; Philip E Putnam; Marc E Rothenberg Journal: Gastroenterology Date: 2007-10-05 Impact factor: 22.682
Authors: Glenn T Furuta; Chris A Liacouras; Margaret H Collins; Sandeep K Gupta; Chris Justinich; Phil E Putnam; Peter Bonis; Eric Hassall; Alex Straumann; Marc E Rothenberg Journal: Gastroenterology Date: 2007-08-08 Impact factor: 22.682
Authors: Matthew S Cohen; Adam B Kaufman; Juan P Palazzo; Daniel Nevin; Anthony J Dimarino; Sidney Cohen Journal: Clin Gastroenterol Hepatol Date: 2007-08-01 Impact factor: 11.382
Authors: Daniel A Schupack; Karthik Ravi; Debra M Geno; Katrina Pierce; Kristin Mara; David A Katzka; Jeffrey A Alexander Journal: Dig Dis Sci Date: 2020-03-12 Impact factor: 3.199
Authors: Jeff Y Yang; Michael Webster-Clark; Jennifer L Lund; Robert S Sandler; Evan S Dellon; Til Stürmer Journal: Gastrointest Endosc Date: 2019-04-30 Impact factor: 9.427